Fawzia Haque
Family Medicine · Broad Top, PANPI 1578752291
Payments from drug & device makers
Across 397 payments — averaging $14.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$852
- GSK$626
- AbbVie$545
- AstraZeneca$360
- Pfizer$236
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,58398%
- Education$1132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 73 | $1,024 |
| Lilly USA, LLC | 67 | $852 |
| GSK | 55 | $626 |
| AbbVie(2 entities) | 29 | $545 |
| AstraZeneca | 24 | $360 |
| Pfizer | 23 | $236 |
| Astellas Pharma US Inc | 9 | $215 |
| Johnson & Johnson | 21 | $192 |
| Sanofi-aventis U.S. LLC | 11 | $168 |
| Exact Sciences | 7 | $148 |
| Boehringer Ingelheim | 9 | $145 |
| Amarin Pharma, Inc. | 8 | $134 |
| Corcept Therapeutics | 7 | $113 |
| Amgen | 7 | $104 |
| Daiichi Sankyo Inc. | 5 | $102 |
| Merck | 6 | $88 |
| E.r. Squibb & Sons, L.L.C. | 6 | $87 |
| Biohaven Pharmaceuticals, Inc. | 3 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Myriad Women's Health, Inc. | 1 | $48 |
| Novartis | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| Abbott | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Medtronic | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Endogastric Solutions, Inc | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Averitas Pharma Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Nevro Corp. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$5,696 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 86 | $70,686 |
| JardianceEmpagliflozin | 51 | $41,337 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 57 | $39,969 |
| MounjaroTirzepatide | 28 | $28,189 |
| TrulicityDulaglutide | 25 | $26,896 |
| XareltoRivaroxaban | 35 | $24,917 |
| OzempicSemaglutide | 16 | $20,175 |
| FarxigaDapagliflozin Propanediol | 19 | $14,803 |
| TradjentaLinagliptin | 12 | $11,467 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $11,211 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $8,463 |
| Varenicline Tartrate | 14 | $4,559 |
| Atorvastatin Calcium | 329 | $4,094 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 26 | $2,751 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 43 | $1,552 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $236 | $70,68686 claims |
| Lilly USA, LLCMounjaro, Trulicity | $852 | $55,08553 claims |
| Boehringer IngelheimJardiance, Tradjenta | $145 | $52,80463 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $626 | $48,43274 claims |
| Johnson & JohnsonXarelto | $192 | $24,91735 claims |
| Novo NordiskOzempic | $1,024 | $20,17516 claims |
| AstraZenecaFarxiga | $360 | $14,80319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Broad Top
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.